Contact Wolverine Compound about our BPC-157 TB-500 coverage.

What to write to us about

This is the contact page for Wolverine Compound, the plain-drawn sketchbook of the BPC-157 TB-500 research record. The most useful messages are about the content itself: a citation that needs correcting, a study we should add, a number that looks off, or a place where the writing could be clearer. We read corrections seriously and update the record when a claim needs fixing, because a digest is only as good as the sources behind it.

The BPC-157 TB-500 literature moves in two directions at once — new component studies arrive, and the regulatory picture shifts, as with the scheduled July 2026 advisory-committee review. If you have spotted a newer peer-reviewed study, a more precise figure, or an FDA update we should reflect, that is exactly the kind of note that improves the site. Please include enough detail for us to verify it independently.

What we cannot do is give medical, clinical, or legal advice. This is no clinic and no prescriber's desk; no clinician sits behind it, and it sells, supplies, and sources no peptide and no blend. For anything involving your own health, please speak with an appropriately licensed professional. Questions about buying or obtaining either peptide are outside what this editorial project does, and we will not be able to help with them.

Send a message

Use the form below to reach the editorial team. Please include enough detail — the page, the claim, and the source if you have one — for us to act on a correction. We do not respond to requests to buy, sell, or source any substance, and we do not provide individual health guidance.